Charles Atkinson

Array ( [id] => 1515401 [patent_doc_number] => 06420521 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-16 [patent_title] => 'Short gastrointestinal peptides' [patent_app_type] => B1 [patent_app_number] => 09/608810 [patent_app_country] => US [patent_app_date] => 2000-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21472 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/420/06420521.pdf [firstpage_image] =>[orig_patent_app_number] => 09608810 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 620126 [patent_doc_number] => 07141541 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-11-28 [patent_title] => 'Use of peptides' [patent_app_type] => utility [patent_app_number] => 10/019198 [patent_app_country] => US [patent_app_date] => 2000-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 16 [patent_no_of_words] => 6793 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/141/07141541.pdf [firstpage_image] =>[orig_patent_app_number] => 10019198 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1014681 [patent_doc_number] => 06894023 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-17 [patent_title] => 'Growth hormone crystals and a process for production of these GH-crystals' [patent_app_type] => utility [patent_app_number] => 09/592032 [patent_app_country] => US [patent_app_date] => 2000-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3505 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/894/06894023.pdf [firstpage_image] =>[orig_patent_app_number] => 09592032 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 773662 [patent_doc_number] => 07001882 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-02-21 [patent_title] => 'Muteins of bilin-binding protein' [patent_app_type] => utility [patent_app_number] => 09/980862 [patent_app_country] => US [patent_app_date] => 2000-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13775 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/001/07001882.pdf [firstpage_image] =>[orig_patent_app_number] => 09980862 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 793201 [patent_doc_number] => 06982247 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-01-03 [patent_title] => 'Compounds exhibiting an antibiotic activity' [patent_app_type] => utility [patent_app_number] => 09/979672 [patent_app_country] => US [patent_app_date] => 2000-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4679 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/982/06982247.pdf [firstpage_image] =>[orig_patent_app_number] => 09979672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 707843 [patent_doc_number] => 07060670 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-06-13 [patent_title] => 'Stereoselective antifibrillogenic peptides and peptidomimetics thereof' [patent_app_type] => utility [patent_app_number] => 10/009122 [patent_app_country] => US [patent_app_date] => 2000-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6238 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/060/07060670.pdf [firstpage_image] =>[orig_patent_app_number] => 10009122 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1014680 [patent_doc_number] => 06894022 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-17 [patent_title] => 'Growth factor modified protein matrices for tissue engineering' [patent_app_type] => utility [patent_app_number] => 09/563760 [patent_app_country] => US [patent_app_date] => 2000-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 12791 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/894/06894022.pdf [firstpage_image] =>[orig_patent_app_number] => 09563760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 985536 [patent_doc_number] => 06924264 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-08-02 [patent_title] => 'Modified exendins and exendin agonists' [patent_app_type] => utility [patent_app_number] => 09/561226 [patent_app_country] => US [patent_app_date] => 2000-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 21 [patent_no_of_words] => 20427 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/924/06924264.pdf [firstpage_image] =>[orig_patent_app_number] => 09561226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1285572 [patent_doc_number] => 06635265 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-21 [patent_title] => 'Materials and methods useful for the control of insect larvae' [patent_app_type] => B1 [patent_app_number] => 09/551738 [patent_app_country] => US [patent_app_date] => 2000-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 16426 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/635/06635265.pdf [firstpage_image] =>[orig_patent_app_number] => 09551738 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1113103 [patent_doc_number] => 06803358 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-10-12 [patent_title] => 'Ricin-like toxin variants for treatment of cancer, viral or parasitic infections' [patent_app_type] => B1 [patent_app_number] => 09/551151 [patent_app_country] => US [patent_app_date] => 2000-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 254 [patent_figures_cnt] => 190 [patent_no_of_words] => 27651 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/803/06803358.pdf [firstpage_image] =>[orig_patent_app_number] => 09551151 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 679117 [patent_doc_number] => 07083777 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-08-01 [patent_title] => 'Immunomodulating polymers' [patent_app_type] => utility [patent_app_number] => 09/540024 [patent_app_country] => US [patent_app_date] => 2000-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 21188 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/083/07083777.pdf [firstpage_image] =>[orig_patent_app_number] => 09540024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 707840 [patent_doc_number] => 07060669 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-06-13 [patent_title] => 'Process for partitioning of proteins' [patent_app_type] => utility [patent_app_number] => 09/936823 [patent_app_country] => US [patent_app_date] => 2000-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 17966 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/060/07060669.pdf [firstpage_image] =>[orig_patent_app_number] => 09936823 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1248080 [patent_doc_number] => 06673609 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-06 [patent_title] => 'Recombinant human erythropoietin with advantageous glycosylation profile' [patent_app_type] => B1 [patent_app_number] => 09/486222 [patent_app_country] => US [patent_app_date] => 2000-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6232 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/673/06673609.pdf [firstpage_image] =>[orig_patent_app_number] => 09486222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1292481 [patent_doc_number] => 06630573 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-07 [patent_title] => 'Tau-conotoxin peptides' [patent_app_type] => B1 [patent_app_number] => 09/497491 [patent_app_country] => US [patent_app_date] => 2000-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15868 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/630/06630573.pdf [firstpage_image] =>[orig_patent_app_number] => 09497491 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 642164 [patent_doc_number] => 07122620 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-10-17 [patent_title] => 'Haptotactic peptides' [patent_app_type] => utility [patent_app_number] => 09/487790 [patent_app_country] => US [patent_app_date] => 2000-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11947 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/122/07122620.pdf [firstpage_image] =>[orig_patent_app_number] => 09487790 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1037551 [patent_doc_number] => 06872700 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-03-29 [patent_title] => 'Methods for glucagon suppression' [patent_app_type] => utility [patent_app_number] => 09/889331 [patent_app_country] => US [patent_app_date] => 2000-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 27 [patent_no_of_words] => 19229 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/872/06872700.pdf [firstpage_image] =>[orig_patent_app_number] => 09889331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7613089 [patent_doc_number] => 06902744 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-06-07 [patent_title] => 'Exendin agonist formulations and methods of administration thereof' [patent_app_type] => utility [patent_app_number] => 09/889330 [patent_app_country] => US [patent_app_date] => 2000-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 35 [patent_no_of_words] => 49705 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/902/06902744.pdf [firstpage_image] =>[orig_patent_app_number] => 09889330 [rel_patent_id] =>[rel_patent_doc_number] =>)